Scilex (SCLX) Competitors $6.00 -0.24 (-3.85%) Closing price 07/3/2025 03:44 PM EasternExtended Trading$6.23 +0.23 (+3.83%) As of 07/3/2025 04:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SCLX vs. ALMS, ELDN, SPRO, ENTA, CGEN, NVCT, ACRS, MOLN, VTYX, and NLTXShould you be buying Scilex stock or one of its competitors? The main competitors of Scilex include Alumis (ALMS), Eledon Pharmaceuticals (ELDN), Spero Therapeutics (SPRO), Enanta Pharmaceuticals (ENTA), Compugen (CGEN), Nuvectis Pharma (NVCT), Aclaris Therapeutics (ACRS), Molecular Partners (MOLN), Ventyx Biosciences (VTYX), and Neoleukin Therapeutics (NLTX). These companies are all part of the "pharmaceutical products" industry. Scilex vs. Its Competitors Alumis Eledon Pharmaceuticals Spero Therapeutics Enanta Pharmaceuticals Compugen Nuvectis Pharma Aclaris Therapeutics Molecular Partners Ventyx Biosciences Neoleukin Therapeutics Alumis (NASDAQ:ALMS) and Scilex (NASDAQ:SCLX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, media sentiment, analyst recommendations and dividends. Which has better earnings and valuation, ALMS or SCLX? Scilex has higher revenue and earnings than Alumis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlumisN/AN/A-$294.23MN/AN/AScilex$56.59M0.74-$72.81M-$29.02-0.21 Is ALMS or SCLX more profitable? Alumis has a net margin of 0.00% compared to Scilex's net margin of -146.93%. Scilex's return on equity of 0.00% beat Alumis' return on equity.Company Net Margins Return on Equity Return on Assets AlumisN/A -406.27% -107.29% Scilex -146.93%N/A -82.65% Do analysts recommend ALMS or SCLX? Alumis currently has a consensus price target of $22.86, indicating a potential upside of 595.80%. Scilex has a consensus price target of $455.00, indicating a potential upside of 7,483.33%. Given Scilex's higher possible upside, analysts plainly believe Scilex is more favorable than Alumis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alumis 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.22Scilex 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do institutionals & insiders have more ownership in ALMS or SCLX? 69.7% of Scilex shares are owned by institutional investors. 40.7% of Alumis shares are owned by insiders. Comparatively, 7.9% of Scilex shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media prefer ALMS or SCLX? In the previous week, Scilex had 1 more articles in the media than Alumis. MarketBeat recorded 1 mentions for Scilex and 0 mentions for Alumis. Alumis' average media sentiment score of 0.00 equaled Scilex'saverage media sentiment score. Company Overall Sentiment Alumis Neutral Scilex Neutral SummaryScilex beats Alumis on 7 of the 12 factors compared between the two stocks. Get Scilex News Delivered to You Automatically Sign up to receive the latest news and ratings for SCLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SCLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCLX vs. The Competition Export to ExcelMetricScilexMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$44.21M$2.91B$5.55B$9.04BDividend YieldN/A2.44%5.22%4.00%P/E Ratio-0.2121.5627.6420.24Price / Sales0.74281.65418.75118.07Price / CashN/A42.7336.8958.10Price / Book-0.227.518.035.67Net Income-$72.81M-$55.14M$3.18B$249.21M7 Day Performance-0.83%4.61%2.93%3.28%1 Month Performance-4.91%0.90%1.72%3.95%1 Year Performance-90.88%5.40%34.39%20.98% Scilex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCLXScilex1.5729 of 5 stars$6.00-3.8%$455.00+7,483.3%-90.9%$44.21M$56.59M-0.2180ALMSAlumis2.8978 of 5 stars$3.00-0.7%$22.86+661.9%N/A$163.23MN/A0.00N/AELDNEledon Pharmaceuticals2.0041 of 5 stars$2.71+0.7%$9.00+232.1%+20.7%$162.28MN/A-1.2910Positive NewsSPROSpero Therapeutics3.9026 of 5 stars$2.90-1.4%$5.00+72.4%+122.1%$162.14M$28.30M-2.27150ENTAEnanta Pharmaceuticals4.0855 of 5 stars$7.56+0.8%$18.00+138.1%-41.1%$161.63M$67.64M-1.67160Positive NewsCGENCompugen1.5563 of 5 stars$1.78+7.2%$4.00+124.7%+14.1%$158.85M$27.86M-11.1370Positive NewsNVCTNuvectis Pharma2.6299 of 5 stars$7.47-1.1%$17.00+127.6%+24.6%$156.05MN/A-6.618ACRSAclaris Therapeutics2.4299 of 5 stars$1.42-3.4%$9.71+584.1%+20.4%$153.76M$17.78M-1.02100MOLNMolecular Partners2.9751 of 5 stars$3.79+0.8%$12.00+216.6%-43.0%$153.04M$5.65M-1.97180VTYXVentyx Biosciences2.398 of 5 stars$2.14-8.5%$10.00+367.3%-3.5%$152.28MN/A-1.2230NLTXNeoleukin TherapeuticsN/A$16.16-2.5%N/A-44.2%$151.87MN/A-5.2090High Trading Volume Related Companies and Tools Related Companies ALMS Alternatives ELDN Alternatives SPRO Alternatives ENTA Alternatives CGEN Alternatives NVCT Alternatives ACRS Alternatives MOLN Alternatives VTYX Alternatives NLTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SCLX) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scilex Holding Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Scilex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SCLX Stock Alerts